Maze Therapeutics, Inc. (MAZE)

NASDAQ: MAZE · Real-Time Price · USD

50.06

-1.77 (-3.42%)

Mar 13, 2026, 2:04 PM EDT - Market open

Maze Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2023
Period Ending	Mar '26 Mar 13, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	2,409	-	-	-
Market Cap Growth	370.31%	-	-	-
Enterprise Value	2,058	0	0	0
Debt / Equity Ratio	0.05	-0.07	-0.12	-0.10
Debt / EBITDA Ratio	-0.14	0.44	-0.52	-0.30
Debt / FCF Ratio	-0.18	0.36	-0.57	-0.32
Net Debt / Equity Ratio	-0.95	0.55	-0.05	0.24
Net Debt / EBITDA Ratio	2.15	-2.79	-0.22	0.63
Net Debt / FCF Ratio	2.62	-2.27	-0.23	0.67
Asset Turnover	0.00	1.07	0	0
Quick Ratio	17.36	9.52	1.79	4.81
Current Ratio	17.70	9.76	2.09	5.11
Return on Equity (ROE)	-178.29%	-15.25%	30.60%	40.69%
Return on Assets (ROA)	-51.19%	36.10%	-89.00%	-74.04%
Return on Invested Capital (ROIC)	-699.89%	193.52%	-307.50%	-330.64%
Return on Capital Employed (ROCE)	-54.84%	41.87%	-106.91%	-85.95%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q